Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, P.O. Box 85500, 3508 GA, Utrecht, The Netherlands.
Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
Eur Arch Otorhinolaryngol. 2021 Sep;278(9):3181-3191. doi: 10.1007/s00405-020-06538-y. Epub 2020 Dec 28.
Approximately 70-80% of patients with cT1-2N0 oral squamous cell carcinoma (OSCC) ultimately prove to have no cancer in the cervical lymphatics on final pathology after selective neck dissection. As a result, sentinel lymph node biopsy (SLNB) has been adopted during the last decade as a diagnostic staging method to intelligently identify patients who would benefit from formal selective lymphadenectomy or neck irradiation. While not yet universally accepted, SLNB is now incorporated in many national guidelines. SLNB offers a less invasive alternative to elective neck dissection (END), and has some advantages and disadvantages. SLNB can assess the individual drainage pattern and, with step serial sectioning and immunohistochemistry (IHC), can enable the accurate detection of micrometastases and isolated tumor cells (ITCs). Staging of the neck is improved relative to END with routine histopathological examination. The improvements in staging are particularly notable for the contralateral neck and the pretreated neck. However, for floor of mouth (FOM) tumors, occult metastases are frequently missed by SLNB due to the proximity of activity from the primary site to the lymphatics (the shine through phenomenon). For FOM cancers, it is advised to perform either elective neck dissection or superselective neck dissection of the preglandular triangle of level I. New tracers and techniques under development may improve the diagnostic accuracy of SLNB for early-stage OSCC, particularly for FOM tumors. Treatment of the neck (either neck dissection or radiotherapy), although limited to levels I-IV, remains mandatory for any positive category of metastasis (macrometastasis, micrometastasis, or ITCs). Recently, the updated EANM practical guidelines for SLN localization in OSCC and the surgical consensus guidelines on SLNB in patients with OSCC were published. In this review, the current evidence and results of SLNB in early OSCC are presented.
约 70-80% 的 cT1-2N0 口腔鳞状细胞癌 (OSCC) 患者在选择性颈部解剖后最终的最终病理检查中发现颈部淋巴结无癌症。因此,在过去十年中,前哨淋巴结活检 (SLNB) 已被采用作为一种诊断分期方法,以智能识别受益于正式选择性淋巴结清扫术或颈部放疗的患者。虽然尚未被普遍接受,但 SLNB 现在已被纳入许多国家指南。SLNB 为选择性颈部解剖 (END) 提供了一种微创替代方法,具有一些优缺点。SLNB 可以评估个体引流模式,并且通过分步连续切片和免疫组织化学 (IHC),可以准确检测到微转移和孤立肿瘤细胞 (ITC)。与常规组织病理学检查相比,颈部分期通过 END 得到改善。与 END 相比,分期的改善在对侧颈部和预处理颈部尤为明显。然而,对于口底 (FOM) 肿瘤,由于原发部位与淋巴结的接近性 (透过现象),SLNB 经常错过隐匿性转移。对于 FOM 癌症,建议进行选择性颈部解剖或 I 水平的腺前三角的超选择性颈部解剖。正在开发的新示踪剂和技术可能会提高 SLNB 对早期 OSCC 的诊断准确性,特别是对于 FOM 肿瘤。颈部的治疗(无论是颈部解剖还是放疗),尽管仅限于 I-IV 级,对于任何阳性转移类别(巨转移、微转移或 ITC)仍然是强制性的。最近,EANM 发布了更新的 OSCC 前哨淋巴结定位实用指南和 OSCC 患者 SLNB 手术共识指南。在这篇综述中,介绍了早期 OSCC 中 SLNB 的当前证据和结果。